Location: Home > Pharma China Web Edition
  • search
  • go
  • News
  • 8/22/2025Innovent Advances Immuno-Oncology with IBI3026 CTA Acceptance
  • 8/22/2025Xuanzhu's Dexitinib Gains Approval for ALK-Positive Advanced NSCLC in ...
  • 8/22/2025NMPA Approves Domestic Hexavalent Rotavirus Vaccine for Children
  • 8/22/2025CARsgen's Satri-cel Becomes First CAR-T Therapy for Solid Tumors to Re...
  • 8/22/2025Kintor's KX-826 Tincture Nabs Triumph in Phase II Male AGA Trial
  • 8/21/2025Anixa Secures First Chinese Patent for Breast Cancer Vaccine Technolog...
  • 8/21/2025China Intensifies Biotech Support Amid Surge in Global Licensing Deals
  • 8/21/2025Novo Nordisk Meets NHC Minister to Strengthen Collaboration
  • 8/21/2025NMPA Lifts Import Suspension on Vasudha's Loratadine API
  • 8/21/2025CStone Gains Major Backing as GIC Acquires 5.49% Stake
  • 8/21/2025Bio-Thera Solutions Taps STADA to Bring BAT1806 to Global Markets
  • 8/21/2025Zelgen Secures FDA IND Approval for Novel Trispecific Cancer Therapy
  • 8/21/2025Novartis' Vanrafia (atrasentan) Gains Regulatory Nod in China as Secon...
  • 8/21/2025Nicox Targets U.S. and China Filings After Second Phase III Win for NC...
  • 8/21/2025Henlius Biotech Expands Oncology Portfolio with Strategic Licensing Ag...
  • 8/21/2025China Proposes Conflict-of-Interest Declarations for Drug Clinical Tri...
  • 8/21/2025China Drafts Guidance on Single-Arm Trials to Support Oncology Drug Ap...
  • 8/20/2025China Drives Asia-Pacific Health Care Transformation Amid Rising Costs...
  • 8/20/2025Vivatides Secures Major Seed Funding to Propel Breakthrough in Oligonu...
  • 8/20/2025Pfizer Advances Pneumococcal Vaccine Development in China with Phase 1...
  • 8/19/2025Eisai Launches First Orexin Receptor Antagonist for Insomnia in China
  • 8/19/2025Onconic's GERD Drug Jaqbo Advances in China Following Phase 3 Success
  • 8/19/2025CSPC Pharma Advances in Biosimilars with Dupilumab Injection Approval
  • 8/19/2025China Unveils Nine Key Healthcare Insurance Priorities for 2025
  • 8/19/2025Innovent Presents Phase 2 Study of Tarlatamab in Third-Line ES-SCLC at...
  • 8/19/2025Aeonvital Biomedical Advances Personalized Cancer Therapies with New F...
  • 8/19/2025RemeGen and Santen Enter into Licensing Deal for Ophthalmic Drug RC28-...
  • 8/19/2025BioNTech's BNT327 Shows Strong Phase II Results as China-Originated Dr...
  • 8/19/2025CANbridge Announces Strategic Partnership and Investment from Baheal 
  • 8/18/2025Pleryon Completes First Closing of Series A Financing
  • Page:44/62 Total number of articles:1857: [First][<<] [42] [43] [44] [45] [46] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group